A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2011
10/13/2011	US20110251206 Squaramide derivatives as CXCR2 antagonist
10/13/2011	US20110251200 Aryl guanidine f1f0-atpase inhibitors and related methods
10/13/2011	US20110251197 Lysosomotropic inhibitors of acid ceramidase
10/13/2011	US20110251182 Agents and methods for treating ischemic and other diseases
10/13/2011	US20110251177 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
10/13/2011	US20110251176 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251168 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/13/2011	US20110251166 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
10/13/2011	US20110251165 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
10/13/2011	US20110251162 Methods of treatment for mrsa infections
10/13/2011	US20110251156 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
10/13/2011	US20110251140 Peptide antagonist of interleukin-15 activity
10/13/2011	US20110251139 Treatment of inflammatory bowel diseases with mammal beta defensins
10/13/2011	US20110251131 Deuterated 2-amino-3-hydroxypropanoic acid derivatives
10/13/2011	US20110251129 Rheumatoid arthritis-preventive agent for oral intake
10/13/2011	US20110251128 THYMOSIN Beta4 PEPTIDES PROMOTE TISSUE REGENERATION
10/13/2011	US20110251126 Intestinal treatment
10/13/2011	US20110250301 Water insoluble helychrisum extract, process for preparing the same and uses thereof
10/13/2011	US20110250300 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
10/13/2011	US20110250299 Organogel compositions and processes for producing
10/13/2011	US20110250281 Fexofenadine Microcapsules and Compositions Containing Them
10/13/2011	US20110250266 Liposomal systems comprising sphingomyelin
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	US20110250259 Method of treating and preventing breast diseases and breast cancer with medicated formula
10/13/2011	US20110250255 Drug coated stent with endosome-disrupting conjugate
10/13/2011	US20110250243 Nanoparticle compositions
10/13/2011	US20110250239 Pharmaceutical and/or cosmetic composition for treating the skin
10/13/2011	US20110250231 Method of using punicic acid to enhance immune response and prevent metabolic disorders
10/13/2011	US20110250227 Composition for treatment of the skin
10/13/2011	US20110250226 Composition containing extracts of fuscoporia obliqua, ganoderma lucidum and phellinus linteus for promoting the proliferation of hematopoietic stem cells
10/13/2011	US20110250215 Structurally-related relaxin-fusion proteins with extended in vivo half-lives
10/13/2011	US20110250210 Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1)
10/13/2011	US20110250206 Markers for determination of patient responsiveness
10/13/2011	US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/13/2011	US20110250197 Pharmaceutical combination
10/13/2011	US20110250195 Antibodies Against IL-25
10/13/2011	US20110250190 Pharmaceutical preparation
10/13/2011	US20110250177 Alpha interferon variants
10/13/2011	US20110250172 Hepatitis c virus inhibitors
10/13/2011	US20110250153 Oligomeric biosurfactants in dermatocosmetic compositions
10/13/2011	US20110250151 Cold process water soluble wax containing powders
10/13/2011	US20110250134 Sustained release nitric oxide from long lived circulating nanoparticles
10/13/2011	US20110250130 Tnf-alpha binding proteins
10/13/2011	CA2795279A1 Antibodies to cd122
10/12/2011	EP2374818A1 High affinity antibodies to human IL-6 receptor
10/12/2011	EP2374794A1 Cyclic amine compounds
10/12/2011	EP2374788A1 Indanyl compounds
10/12/2011	EP2374478A1 Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
10/12/2011	EP2374453A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
10/12/2011	EP2374452A1 Nutrient composition
10/12/2011	EP2373610A1 Plant extracts from acronychia species and their use
10/12/2011	EP2373318A1 Imidazopyrazine syk inhibitors
10/12/2011	EP2373160A1 Topically active steroids for use in radiation and chemotherapeutics injury
10/12/2011	EP1893191B1 Medicinal acidic cannabinoids
10/12/2011	EP1778238B1 Dihydropteridinone infusion solution having a long shelf life
10/12/2011	EP1448995B9 Assay for screening candidate drugs for the treatment of inflammatory diseases
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN102216291A Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
10/12/2011	CN102216277A Novel compounds as cannabinoid receptor ligands
10/12/2011	CN102216260A Amino acid derivative
10/12/2011	CN102215873A Dendritic cell modulatory molecule
10/12/2011	CN102215835A A medicinal product and treatment
10/12/2011	CN102215833A Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
10/12/2011	CN102212109A Bone polypeptide compound separated from ossotide injection and application thereof
10/12/2011	CN102212091A High-purity geniposide as well as preparation and clinical application of preparations thereof
10/12/2011	CN102212021A Sodium paeonol sulfonate crystalline hydrate, and preparation method and application thereof
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN102210852A Treatment of T-cell mediated diseases
10/12/2011	CN102210845A Traditional Chinese medicine for treating osseous joint pains
10/12/2011	CN102210832A Medicinal plaster for treating shoulder and low back pain and warming uteruses of lying-in women
10/12/2011	CN102210813A Traditional Chinese medicine composition for diminishing inflammation and relieving toxicity for livestock and poultry and preparation method thereof
10/12/2011	CN102210795A Traditional Chinese medicine composition for treating various pains
10/12/2011	CN102210793A Traditional Chinese medicine composition for treating cold and preparation method thereof
10/12/2011	CN102210788A Health-care wine
10/12/2011	CN102210778A Medicine for treating scapulohumeral periarthritis and preparation method thereof
10/12/2011	CN102210777A Chinese medicine composition for treating sepsis and preparation method thereof
10/12/2011	CN102210776A Medicament for treating common cold, and preparation method thereof
10/12/2011	CN102210774A Medicine for treating rheumatism
10/12/2011	CN102210763A Chinese medicinal composition for promoting blood circulation, removing blood stasis, promoting qi circulation and relieving pain and preparation method thereof
10/12/2011	CN102210760A Application of Chinese medicinal component in preparation of medicament for treating chronic epididymitis
10/12/2011	CN102210758A Application of Chinese medicine composition in preparation of medicine for treating ankylosing spondylitis
10/12/2011	CN102210744A Anti-virus infection traditional Chinese medicine composition
10/12/2011	CN102210740A Application of radix astragali
10/12/2011	CN102210736A Medicine composition for treating tenosynovitis and preparation method thereof
10/12/2011	CN102210729A Hemlock parsley ointment and preparation method thereof
10/12/2011	CN102210727A Application of radix isatidis
10/12/2011	CN102210726A Method for combined extraction of mallow flavones and mallow saponins in seashore mallow and application
10/12/2011	CN102210724A Comprehensive use of ovateleaf holly bark medicinal material
10/12/2011	CN102210718A Method for preparing composite-probiotic-fermented Chinese herbal medicine
10/12/2011	CN102210691A Use of crataegolic acid and derivatives thereof in preparation of therapeutic and/or preventive medicines for inhibiting osteoclast differentiation and function
10/12/2011	CN102210685A Application of ectoine and derivatives thereof in preparing medicament for preventing and treating digestive tract diseases caused by chemotherapy medicaments
10/12/2011	CN102210680A Sinomenine derivatives for treating inflammatory disease by blocking macrophage p38 MAPK (mitogen activated protein kinase) signal transduction pathway
10/12/2011	CN102210673A Cyclodextrin inclusion compound containing ligustilide, and preparation method thereof
10/12/2011	CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes
10/12/2011	CN102210636A Antibacterial and skin-moisturizing shaving cream
10/12/2011	CN101850093B Medicinal composition for treating hyperplasia of mammary glands
10/12/2011	CN101695558B Traditional Chinese medicinal composition for treating traumatic injury and rheumatism paralysis and preparation method thereof
10/12/2011	CN101618129B Chinese medical preparation for treating rheumatoid osteopathia
10/12/2011	CN101575582B Lactobacillus separation strains with anti-inflammatory activity and application thereof

1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 1272